Clinical trial
NGR-TNF in Treating Patients With Advanced Solid Tumors
NCT00098943 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00098943 |
|---|---|
| Title | NGR-TNF in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Trial of NGR-TNF Administered Every 3 Weeks as a 1 Hour Intravenous Infusion in Patients With Solid Tumor |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological |
| Interventions | CNGRC peptide-TNF alpha conjugate |
| Enrollment | 70 |
| Start date | Sep 1, 2004 |
| Primary completion | Nov 1, 2007 |
| First posted | Dec 9, 2004 |
| Last update posted | Sep 24, 2012 |
| Countries | Germany, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: